CDC and FDA Address Yellow Fever Vaccine Shortage — Physician’s First Watch
CDC and FDA Address Yellow Fever Vaccine Shortage
By the Editors
The FDA has authorized use of an international yellow fever vaccine (Stamaril) in the United States because supply of the only U.S.-licensed yellow fever vaccine (YF-VAX) is expected to be depleted by the middle of 2017, the CDC reports in MMWR.
The YF-VAX shortage resulted from manufacturing problems. Stamaril uses the same virus substrain as YF-VAX, and is similarly safe and efficacious.
The CDC recommends yellow fever vaccination for people aged 9 months and older who are traveling to or living in high-risk areas in South America and Africa.